Last reviewed · How we verify
NCT05279183
Assessment of Reward Responses to Erythritol Using Flavor Preference Learning
NA trial testing Erythritol in Reward Responses in 20 participants. Completed in 16 September 2022.
16 September 2022
Quick facts
| Lead sponsor | University Hospital, Basel, Switzerland |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | quadruple |
| Primary purpose | basic science |
| Enrollment | 20 |
| Start date | 17 March 2022 |
| Primary completion | 16 September 2022 |
| Estimated completion | 16 September 2022 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
Conditions studied
- Reward Responses — all drugs for Reward Responses →
- Gastrointestinal Hormones — all drugs for Gastrointestinal Hormones →
- Glycemic Control — all drugs for Glycemic Control →
- Appetite — all drugs for Appetite →
Sponsor
University Hospital, Basel, Switzerland
Who can join
Adults 18 to 55, any sex, with Reward Responses or Gastrointestinal Hormones. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this project is to investigate the reward responses to oral erythritol compared to sucrose and sucralose using flavor preference learning in healthy participants. In addition, the release of GI hormones, glycemic control, appetite-related sensations, and emotional state in response to erythritol will be investigated.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05279183
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Erythritol
Trials testing the same drug.
- NCT07377097 — Effects of Sweetener Consumption on Risk Factors for Heart Disease in Prediabetic Subjects · NA · not yet recruiting
- NCT04713137 — Effects of Oral Pre-loads on Subsequent Energy Intake · NA · completed
- NCT04027283 — Acute Effects of the Two Alternative Sweeteners D-allulose and Erythritol on Metabolism · NA · completed
- NCT02934321 — Assessment of Satiety Following Oral Administration of an Erythritol Sweetened Beverage · NA · completed
Other University Hospital, Basel, Switzerland trials
Trials by the same sponsor.
- NCT07444788 — Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants · Phase 1 · recruiting
- NCT07494214 — Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants · Phase 1 · recruiting
- NCT07419048 — Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status · recruiting
- NCT06978777 — Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity · NA · recruiting
- NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05279183 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Basel, Switzerland
- Last refreshed: 12 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05279183.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing